Long-term oxygen therapy to reduce length of hospital stay in COVID-19

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorda Silva, Douglas Inomata Cardoso-
Autor(es): dc.creatorIshimoto, Letícia Yumi-
Autor(es): dc.creatorFranco, Estefânia Aparecida Thomé-
Autor(es): dc.creatordos Santos, Maércio Souza Cícero-
Autor(es): dc.creatorBrizola, Luís Fernando Pereira-
Autor(es): dc.creatorColombo, Camila Aparecida-
Autor(es): dc.creatorSavadkouhi, Edris Guardiano-
Autor(es): dc.creatorMachado, Luiz Henrique Soares-
Autor(es): dc.creatorTanni, Suzana Erico-
Autor(es): dc.creatorPrudente, Robson-
Data de aceite: dc.date.accessioned2025-08-21T17:00:32Z-
Data de disponibilização: dc.date.available2025-08-21T17:00:32Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1590/1806-9282.20231379-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/298519-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/298519-
Descrição: dc.descriptionOBJECTIVE: The aim of this study was to evaluate the efficacy of long-term oxygen therapy as a strategy to reduce hospitalization time in patients affected by COVID-19. METHODS: Between April and December 2021, COVID-19 patients with stable clinical conditions needing supplementary oxygen therapy during hospitalization were oriented to have hospital discharge with long-term oxygen therapy and reassessment after 15 days. RESULTS: A total of 62 patients were evaluated and, 15 days after discharge, 69% of patients had suspended long-term oxygen therapy, with no difference between the groups admitted to the intensive care unit or the ward (p=0.319). Among the individuals who needed to maintain long-term oxygen therapy, in addition to worse P/F ratio (265±57 vs. 345±51; p<0.001) and lower partial pressure of oxygen (55±12 vs. 72±11 mmHg; p<0.001), were those more obese (37±8 vs. 30±6 kg/m2; p=0.032), needed more time for invasive mechanical ventilation (46±27 vs. 20±16 days; p=0.029), had greater persistence of symptoms (p<0.001), and shorter time between the onset of symptoms and the need for hospitalization (7 [2–9] vs. 10 [6–12] days; p=0.039). CONCLUSION: Long-term oxygen therapy is an effective strategy for reducing hospitalization time in COVID-19 patients, regardless of gravity. Additionally, more obese patients with persistence of respiratory symptoms, faster disease evolution, and more days of invasive mechanical ventilation needed to maintain the long-term oxygen therapy longer.-
Descrição: dc.descriptionSão Paulo State University (UNESP) Medical School, Distrito de Rubião Junior s/n, SP-
Descrição: dc.descriptionSão Paulo State University (UNESP) Medical School, Distrito de Rubião Junior s/n, SP-
Idioma: dc.languageen-
Relação: dc.relationRevista da Associacao Medica Brasileira-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectHospitalization-
Palavras-chave: dc.subjectHypoxemia-
Palavras-chave: dc.subjectOxygen inhalation therapy-
Palavras-chave: dc.subjectSARS-CoV-2-
Título: dc.titleLong-term oxygen therapy to reduce length of hospital stay in COVID-19-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.